-
Charity Urges Price Cut for Pneumonia Vaccine for Poor Children
Global charity Medecins Sans Frontieres delivered a petition with hundreds of thousands of signatures to pharmaceutical giant Pfizer Inc on Wednesday, asking the drugmaker to slash the price of its pneumonia vaccine for poor children.
- Categories
- Health Care
- Tags
- vaccines
-
Cheap Device for Examining Eyes Successfully Tested
A simple eye examining device that may offer a cheap way to improve medical care and training in developing countries has been successfully tested in Africa and Pacific island states.
- Categories
- Health Care
-
Hikma Pharmaceuticals Launches $30M Digital Health Venture Fund in Amman
Hikma Pharmaceuticals has launched a $30 million strategic venture capital fund focused on digital health, therapeutics, and diagnostics startups.Founded in August 2015, the Amman-based Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals.
- Categories
- Health Care, Investing
- Region
- North Africa & Near East
-
Mobile Phone Companies Oppose ‘Panic Button’ Move, Say Will Push Up the Prices for Basic Phones
Handset makers have opposed the government's move mandating global positioning system (GPS) on feature phones, arguing it would hit users at the lowest level as the cost of basicphones would go up by Rs 400 — a massive increase in a market where the cheapest device is available for Rs 500.
- Categories
- Health Care
-
Closing the Gap on Vaccine Efficacy in the ‘Global South’
Vaccines and antibiotics occupy a privileged position in the history of medicine. They are humanity’s “magic bullets” — categories of intervention so effective and easy to deliver that they have the capacity to single-handedly eradicate entire diseases from human history. But just as the heady utopia of an antibiotic age has given way to the cold, evolutionary reality of antibiotic resistance, we must now also confront the pervasive problem of vaccine failure in the global South.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
Kenya’s New Favorite Customer: Iran
On his first trip to Iran last June, Joseph Kamau Kiminda quickly learned that Iranians care about a few things more than tea. The CEO of Kenyan tea company, Cup of Joe, spent time with everyday Iranians who, immediately after rolling out of bed, put tea to boil, leaving it on all day. His Iranian business counterparts called him most days, including Saturdays, at six in the morning to discuss tea for three to four hours. He even received a lecture on tea quality from the secretary of an Iranian tea distributor. “They know tea,” Kiminda concluded.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Inside the High-Stakes World of Vaccine Development
Vaccines are widely recognized as the most effective way we’ve got to fight infectious disease, a bulwark against a staggeringly diverse array of potentially pathogenic organisms looking to circumvent our defenses. Pervasive vaccines like those for influenza, measles, or polio offer a sense of security, but it wasn’t always so, and a range of established and emerging threats continue to present real problems. Given the physical interconnectedness of even the most remote locations with the rest of the world, esoteric pathogens have a fast track to global transmission like never before.
- Categories
- Health Care
- Tags
- vaccines
-
Sun Pharma Joins Hands With ICMR for Malaria Eradication Prog
In a first of its kind of public private partnership (PPP), pharmaceutical giant Sun Pharma has collaborated with the Indian Council of Medical Research (ICMR) to eradicate malaria by 2030.
- Categories
- Health Care
- Region
- South Asia
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.